DFN-11, a 3 mg subcutaneous sumatriptan autoinjector, may provide an alternative to SC sumatriptan 6 mg for individuals with episodic migraine.
GammaCore Sapphire, a new non-invasive hand-held device for migraine and episodic cluster headache treatment, has been made available by electroCore.
For patients with episodic migraine, galcanezumab is better than placebo for reducing migraine headache days.
Fremanezumab slightly decreased the amount of headache free days in those with episodic migraines compared to placebo.
Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.
For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.
Both erenumab and fremanezumab are currently under review by the FDA for the treatment of migraine.
Clinicians need to consider treatments for episodic migraine that may be contraindicated if a patient also has cardiovascular disease.
Future predictive models may need to include other migraine risk factors to enhance predictive accuracy.
Treatment with the monoclonal antibody erenumab reduced the number of monthly migraine days experienced in patients with episodic migraine.
Over 50% of participants reported having an inadequate response to treatment.
Phase 2 results show anti-CGRP receptor monoclonal antibody effective for the prevention of episodic migraine.
Treatment that provides rapid, consistent migraine relief may help mediate factors that promote inadequate treatment response.
Adults taking the drug combo experienced a decreased amount of migraine days compared to placebo.
A simple lipid panel may distinguish those with episodic migraine.
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Drug Prices Increase More Than Expected After Shortages
- Potentially Inappropriate Opioid Prescribing Tied to Overdose
- Loss of Function Variants in LRKK1 and LRKK2 Not Linked to Parkinson Disease
- Scribes Improve Physician Workflow, Patient Interaction